Have a personal or library account? Click to login
Markers of cognitive impairment in patients with type 2 diabetes Cover

Markers of cognitive impairment in patients with type 2 diabetes

Revista Romana de Medicina de Laborator
Volume 24 (2016): Issue 2 (June 2016)
By: Simona Cernea,  Floredana-Laura Şular,  Adina Huţanu and  Septimiu Voidăzan  
Open Access
|Jun 2016

References

  1. 1. Reijmer YD, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ. Co+gnitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev. 2010;26(7):507-19. DOI: 10.1002/dmrr.1112.10.1002/dmrr.111220799243
    Search in Google Scholar
  2. 2. Feinkohl I, Price JF, Strachan MW, Frier BM. The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors. Alzheimers Res Ther. 2015;7(1):46. DOI: 10.1186/s13195-015-0130-5.10.1186/s13195-015-0130-5446063526060511
    Search in Google Scholar
  3. 3. Bordier L, Doucet J, Boudet J, Bauduceau B. Update on cognitive decline and dementia in elderly patients with diabetes. Diabetes Metab. 2014;40(5):331-7. DOI: 10.1016/j.diabet.2014.02.002.10.1016/j.diabet.2014.02.00224703603
    Search in Google Scholar
  4. 4. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2015;38(Suppl. 1):S41-S48.10.2337/dc15-S01025537707
    Search in Google Scholar
  5. 5. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA:A Brief Screening Tool For Mild Cognitive Impairment. J Am Geriatr Soc 53:695-699, 2005. DOI: 10.1111/j.1532-5415.2005.53221.x.10.1111/j.1532-5415.2005.53221.x15817019
    Search in Google Scholar
  6. 6. HOMA software downloaded from site https://www.dtu.ox.ac.uk/homacalculator/download.php.
    Search in Google Scholar
  7. 7. Cernea S, Zoltai C, Berbecilă D, Şular FL. Prevalence of depression, anxiety and cognitive impairment in patients with type 2 diabetes from the Central part of Romania. Acta Medica Marisiensis. 2016 Apr 27; [Epub ahead of print]. DOI: 10.1515/amma-2016-0014.10.1515/amma-2016-0014
    Search in Google Scholar
  8. 8. Mayeda ER, Whitmer RA, Yaffe K. Diabetes and cognition. Clin Geriatr Med. 2015;31(1):101-15. DOI: 10.1016/j.cger.2014.08.021.10.1016/j.cger.2014.08.021437022125453304
    Search in Google Scholar
  9. 9. Biessels GJ, Reijmer YD. Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Diabetes. 2014;63(7):2244-52. DOI: 10.2337/db14-0348.10.2337/db14-034824931032
    Search in Google Scholar
  10. 10. Jongen C, van der Grond J, Kappelle LJ, Biessels GJ, Viergever MA, Pluim JP. Utrecht Diabetic Encephalopathy Study Group. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia. 2007;50(7):1509-16. DOI: 10.1007/s00125-007-0688-y.10.1007/s00125-007-0688-y191430017492428
    Search in Google Scholar
  11. 11. Reijmer YD, van den Berg E, de Bresser J, Kessels RP, Kappelle LJ, Algra A, et al. Utrecht Diabetic Encephalopathy Study Group. Accelerated cognitive decline in patients with type 2 diabetes:MRI correlates and risk factors. Diabetes Metab Res Rev. 2011;27(2):195-202. DOI: 10.1002/dmrr.1163.10.1002/dmrr.116321294241
    Search in Google Scholar
  12. 12. Guerrero-Berroa E, Ravona-Springer R, Schmeidler J, Silverman JM, Sano M, Koifmann K, et al. Age, gender, and education are associated with cognitive performance in an older Israeli sample with type 2 diabetes. Int J Geriatr Psychiatry. 2014;29(3):299-309. DOI: 10.1002/gps.4008.10.1002/gps.4008391824223925856
    Search in Google Scholar
  13. 13. Hayashi K, Kurioka S, Yamaguchi T, Morita M, Kanazawa I, Takase H, et al. Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes. Diabetes Res Clin Pract. 2011;94(2):180-5. DOI: 10.1016/j.diabres.2011.07.002.10.1016/j.diabres.2011.07.00221835484
    Search in Google Scholar
  14. 14. Ruis C, Biessels GJ, Gorter KJ, van den Donk M, Kappelle LJ, Rutten GE. Cognition in the early stage of type 2 diabetes. Diabetes Care. 2009;32(7):1261-5. DOI: 10.2337/dc08-2143.10.2337/dc08-2143269974119366968
    Search in Google Scholar
  15. 15. Fischer AL, de Frias CM, Yeung SE, Dixon RA. Short-term longitudinal trends in cognitive per formance in older adults with type 2 diabetes. J Clin Exp Neuropsychol. 2009;31(7):809-22. DOI: 10.1080/13803390802537636.10.1080/13803390802537636282909819142776
    Search in Google Scholar
  16. 16. van den Berg E, Reijmer YD, de Bresser J, Kessels RP, Kappelle LJ, Biessels GJ. Utrecht Diabetic Encephalopathy Study Group. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(1):58-65. DOI: 10.1007/s00125-009-1571-9.10.1007/s00125-009-1571-9278993519882137
    Search in Google Scholar
  17. 17. Mori Y, Futamura A, Murakami H, Kohashi K, Hirano T, Kawamura M. Increased detection of mild cognitive impairment with type 2 diabetes mellitus using the Japanese version of the Montreal Cognitive Assessment: A pilot study. Neurology and Clinical Neuroscience. 2015, 3(3):89-93. DOI: 10.1111/ncn3.153.10.1111/ncn3.153
    Search in Google Scholar
  18. 18. Sadanand S, Balachandar R, Bharath S. Memory and executive functions in persons with type 2 diabetes:a meta- analysis. Diabetes Metab Res Rev. 2016;32(2):132-42. DOI: 10.1002/dmrr.2664.10.1002/dmrr.266425963303
    Search in Google Scholar
  19. 19. Spauwen PJ, Köhler S, Verhey FR, Stehouwer CD, van Boxtel MP. Effects of type 2 diabetes on 12-year cognitive change:results from the Maastricht Aging Study. Diabetes Care. 2013;36(6):1554-61. DOI: 10.2337/dc12-0746.10.2337/dc12-0746366184823275366
    Search in Google Scholar
  20. 20. Samaras K, Lutgers HL, Kochan NA, Crawford JD, Campbell LV, Wen W, et al. The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study. Age (Dordr). 2014;36(2):977-93. DOI: 10.1007/s11357-013-9613-0.10.1007/s11357-013-9613-0403924624402401
    Search in Google Scholar
  21. 21. Julayanont P, Phillips N, Chertkow H, Nasreddine ZS. Montreal Cognitive Assessment (MoCA): Concept and Clinical Review. In Larner A. J. (ed). Cognitive Screening Instruments: A Practical Approach. 2013, Springer-Verlag, pp:111-51. DOI: 10.1007/978-1-4471-2452-8_6.10.1007/978-1-4471-2452-8_6
    Search in Google Scholar
  22. 22. Cherbuin N, Sachdev P, Anstey KJ. Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study. Neurology. 2012;79(10):1019-26. DOI: 10.1212/WNL.0b013e31826846de.10.1212/WNL.0b013e31826846de22946113
    Search in Google Scholar
  23. 23. Jones N, Riby LM, Mitchell RL, Smith MA. Type 2 diabetes and memory: using neuroimaging to understand the mechanisms. Curr Diabetes Rev. 2014;10(2):118-23. DOI: 10.2174/1573399810666140425160811.10.2174/157339981066614042516081124766069
    Search in Google Scholar
  24. 24. Li R, Singh M. Sex differences in cognitive impairment and Alzheimer’s disease. Front Neuroendocrinol. 2014;35(3):385-403. DOI: 10.1016/j. yfrne.2014.01.002.
    Search in Google Scholar
  25. 25. Corsonello A, Pedone C, Pahor M, Malara A, Carosella L, Mazzei B, et al. Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA). Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients. Magnes Res. 2001;14(4):273-82.
    Search in Google Scholar
  26. 26. Barbagallo M, Belvedere M, Di Bella G, Dominguez LJ. Altered ionized magnesium levels in mild-to-moderate Alzheimer’s disease. Magnes Res. 2011;24(3):S115-21.10.1684/mrh.2011.028721951617
    Search in Google Scholar
  27. 27. Andrási E, Páli N, Molnár Z, Kösel S. Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients. J Alzheimers Dis. 2005;7(4):273-84.10.3233/JAD-2005-7402
    Search in Google Scholar
  28. 28. Gerhardsson L, Lundh T, Minthon L, Londos E. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord. 2008;25(6):508-15. DOI: 10.1159/000129365.10.1159/00012936518463412
    Search in Google Scholar
  29. 29. Cherbuin N, Kumar R, Sachdev PS, Anstey KJ. Dietary Mineral Intake and Risk of Mild Cognitive Impairment: The PATH through Life Project. Front Aging Neurosci. 2014;6:4. DOI: 10.3389/fnagi.2014.00004.10.3389/fnagi.2014.00004391243324550825
    Search in Google Scholar
  30. 30. Gómez-Ramos A, Domínguez J, Zafra D, Corominola H, Gomis R, Guinovart JJ, et al. Inhibition of GSK3 dependent tau phosphorylation by metals. Curr Alzheimer Res. 2006;3(2):123-7. DOI: 10.2174/156720506776383059.10.2174/15672050677638305916611012
    Search in Google Scholar
  31. 31. Yu J, Sun M, Chen Z, Lu J, Liu Y, Zhou L, et al. Magnesium modulates amyloid-beta protein precursor trafficking and processing. J Alzheimers Dis. 2010;20(4):1091-106.10.3233/JAD-2010-09144420413885
    Search in Google Scholar
  32. 32. Wang P, Yu X, Guan PP, Guo JW, Wang Y, Zhang Y, et al. Magnesium ion influx reduces neuroinflammation in Aβ precursor protein/Presenilin 1 transgenic mice by suppressing the expression of interleukin-1β. Cell Mol Immunol. 2015 Nov 9. [Epub ahead of print]. DOI: 10.1038/cmi.2015.93.10.1038/cmi.2015.93542308726549801
    Search in Google Scholar
  33. 33. Xu ZP, Li L, Bao J, Wang ZH, Zeng J, Liu EJ, et al. Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer’s model. PLoS One. 2014;9(9):e108645. DOI: 10.1371/journal.pone.0108645.10.1371/journal.pone.0108645418255425268773
    Search in Google Scholar
  34. 34. Barbagallo M, Dominguez LJ. Magnesium and type 2 diabetes. World J Diabetes. 2015;6(10):1152-7. DOI: 10.4239/wjd.v6.i10.1152. 10.4239/wjd.v6.i10.1152454966526322160
    Search in Google Scholar
  35. 35. Liu G, Weinger JG, Lu ZL, Xue F, Sadeghpour S. Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo- Controlled Trial. J Alzheimers Dis. 2015;49(4):971-90. DOI: 10.3233/JAD-150538.10.3233/JAD-150538492782326519439
    Search in Google Scholar
  36. 36. West R, Beeri MS, Schmeidler J, Hannigan CM, Angelo G, Grossman HT, et al. Better memory functioning associated with higher total and LDL cholesterol levels in very elderly subjects without the APOE4 allele. Am J Geriatr Psychiatry. 2008;16(9):781-5. DOI: 10.1097/ JGP.0b013e3181812790.10.1097/JGP.0b013e3181812790261455518757771
    Search in Google Scholar
  37. 37. Leritz EC, McGlinchey RE, Salat DH, Milberg WP. Elevated levels of serum cholesterol are associated with better performance on tasks of episodic memory. Metab Brain Dis. 2016;31(2):465-73. DOI: 10.1007/ s11011-016-9797-y.10.1007/s11011-016-9797-y491347426873100
    Search in Google Scholar
  38. 38. Wang SH, Huang Y, Yuan Y, Xia WQ, Wang P, Huang R. LDL receptor knock-out mice show impaired spatial cognition with hippocampal vulnerability to apoptosis and deficits in synapses. Lipids Health Dis. 2014;13:175. DOI: 10.1186/1476-511X-13-175.10.1186/1476-511X-13-175425803925413784
    Search in Google Scholar
  39. 39. Gunstad J, Spitznagel MB, Keary TA, Glickman E, Alexander T, Karrer J, et al. Serum leptin levels are associated with cognitive function in older adults. Brain Res. 2008;1230:233-6. DOI: 10.1016/j.brainres.2008.07.045.10.1016/j.brainres.2008.07.04518675793
    Search in Google Scholar
  40. 40. Labad J, Price JF, Strachan MW, Deary IJ, Seckl JR, Sattar N, et al. Edinburgh Type 2 Diabetes Study Investigators. Serum leptin and cognitive function in people with type 2 diabetes. Neurobiol Aging. 2012;33(12):2938-41. DOI: 10.1016/j.neurobiolaging.2012.02.026.10.1016/j.neurobiolaging.2012.02.02622475620
    Search in Google Scholar
DOI: https://doi.org/10.1515/rrlm-2016-0023 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 161 - 176
Submitted on: Mar 28, 2016
|
Accepted on: May 10, 2016
|
Published on: Jun 28, 2016
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
type 2 diabetes,
cognitive function,
cognitive domains,
serum magnesium,
age
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2016 Simona Cernea, Floredana-Laura Şular, Adina Huţanu, Septimiu Voidăzan, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 24 (2016): Issue 2 (June 2016)Next article